Evidence map›Paper›PMID 41339059›Full record

ArticleGut2026

SIRT6-GLUL axis: rewiring nitrogen metabolism in intrahepatic cholangiocarcinoma.

Huiping Zhou, Hui Li, Nan Wu, Diego F Calvisi

Abstract read
In one paragraph

Article in Gut, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Huiping ZhouDepartment of Microbiology and Immunology, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA diego.calvisi@ur.de Huiping.Zhou@vcuhealth.org.ORCID http://orcid.org/0000-0002-0050-372X
Hui LiDepartment of Microbiology and Immunology, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.
Nan WuDepartment of Microbiology and Immunology, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.
Diego F CalvisiInstitute of Pathology, University of Regensburg, Regensburg, Germany diego.calvisi@ur.de Huiping.Zhou@vcuhealth.org.

Funding

Mouse Model and Pathological Analysis CoreP01CA275740 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI Devanand Sarkar · 2024 to 2026
$10.6M
Circular RNAs in Cholestatic Liver DiseasesR01DK139587 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI HUIPING ZHOU · 2024 to 2026
$2.2M
LncRNA H19 in Cholestatic Liver DiseasesR01DK115377 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI HYLEMON, PHILLIP B, ZHOU, HUIPING ROSE · 2018 to 2021
$2.1M
Sphingolipids in alcoholic liver diseaseR01AA030180 · NIAAA · VIRGINIA COMMONWEALTH UNIVERSITY · PI PHILLIP B HYLEMON, HUIPING ZHOU · 2023 to 2026
$2.1M
LncRNA H19 in Cholestatic Liver DiseasesR56DK115377 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI HYLEMON, PHILLIP B, ZHOU, HUIPING ROSE · 2023 to 2023
$630k
BLRD VA I01 BX005730BLRD VA IK6 BX004477NCI NIH HHS P01 CA275740NIAAA NIH HHS R01 AA030180NIDDK NIH HHS R01 DK115377NIDDK NIH HHS R01 DK139587NIDDK NIH HHS R56 DK115377
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CHOLANGIOCARCINOMALIPID METABOLISMLIVER METABOLISMOXIDATIVE STRESS

Identifiers

PMID41339059
PMCPMC12869318

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.